Abstract
Dual-action antidepressants (duloxetine, mirtazapine, venlafaxine) are widely used in clinical practice. The author comments and compare their mutual efficacy in the treatment of major depression, tolerability, use in other indications and in the treatment of special populations (depression in old age, pregnancy, breast-feeding).